287 related articles for article (PubMed ID: 28356114)
1. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials.
Wang X; Zheng H; Shou T; Tang C; Miao K; Wang P
J Orthop Surg Res; 2017 Mar; 12(1):52. PubMed ID: 28356114
[TBL] [Abstract][Full Text] [Related]
2. Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.
Zhang T; Zhang S; Yang F; Wang L; Zhu S; Qiu B; Li S; Deng Z
J Cell Biochem; 2018 Jan; 119(1):250-259. PubMed ID: 28266080
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.
Souhami RL; Craft AW; Van der Eijken JW; Nooij M; Spooner D; Bramwell VH; Wierzbicki R; Malcolm AJ; Kirkpatrick A; Uscinska BM; Van Glabbeke M; Machin D
Lancet; 1997 Sep; 350(9082):911-7. PubMed ID: 9314869
[TBL] [Abstract][Full Text] [Related]
4. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
Anninga JK; Gelderblom H; Fiocco M; Kroep JR; Taminiau AH; Hogendoorn PC; Egeler RM
Eur J Cancer; 2011 Nov; 47(16):2431-45. PubMed ID: 21703851
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.
Zhang B; Zhang Y; Li R; Li J; Lu X; Zhang Y
J Orthop Surg Res; 2020 Feb; 15(1):51. PubMed ID: 32054494
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Outcome and Patient Safety of Methotrexate, Doxorubicin, and Cisplatin Regimen for Chemotherapy in Osteosarcoma: A Meta-Analysis.
Ismail MD; Wiratnaya IGE; Raditya RH
Asian Pac J Cancer Prev; 2024 May; 25(5):1497-1505. PubMed ID: 38809621
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis.
Fan XL; Cai GP; Zhu LL; Ding GM
Drug Des Devel Ther; 2015; 9():5925-32. PubMed ID: 26604690
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant form.
Avella M; Bacci G; McDonald DJ; Di Scioscio M; Picci P; Campanacci M
Chemioterapia; 1988 Apr; 7(2):133-7. PubMed ID: 3165057
[TBL] [Abstract][Full Text] [Related]
11. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Meyers PA; Gorlick R; Heller G; Casper E; Lane J; Huvos AG; Healey JH
J Clin Oncol; 1998 Jul; 16(7):2452-8. PubMed ID: 9667263
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the efficacy and safety of first-line chemotherapeutic agents for osteosarcoma.
Li Z; Ma X; Wang Z; Dong S; Wang B
Adv Clin Exp Med; 2024 May; 33(5):445-454. PubMed ID: 37747442
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
[TBL] [Abstract][Full Text] [Related]
15. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
16. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
17. Survival Differences of Patients with Resected Extraskeletal Osteosarcoma Receiving Two Different (Neo)Adjuvant Chemotherapy Regimens: A Systematic Review and Meta-analysis.
Campos F; Téres R; Sebio A; Bettim BB; Martinez-Trufero J
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e720-e727. PubMed ID: 37777356
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for osteosarcoma.
Eilber FR; Rosen G
Semin Oncol; 1989 Aug; 16(4):312-22. PubMed ID: 2667146
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy among multiple chemotherapeutic interventions combined with radiation therapy for patients with cervix cancer after surgery: A network meta-analysis.
Chang L; Guo R
Oncotarget; 2017 Jul; 8(30):49515-49533. PubMed ID: 28472781
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for pediatric osteosarcoma patients.
Uchida A; Myoui A; Araki N; Yoshikawa H; Shinto Y; Ueda T
Cancer; 1997 Jan; 79(2):411-5. PubMed ID: 9010116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]